This inventor holds 1 USPTO granted patent. Top assignee: The University of Amsterdam. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Upendra Kumar Pandit: Innovator in Glucosylceramidase Inhibition
Introduction
Upendra Kumar Pandit is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of glucosylceramidase inhibitors. His work is crucial for advancing treatments for diseases that involve ceramide-mediated signaling processes.
Latest Patents
Upendra Kumar Pandit holds a patent for "Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors." This patent describes deoxynojirimycin derivatives that contain a large hydrophobic moiety, such as cholesterol or adamantame-methanol, linked through a spacer to the nitrogen atom of deoxynojirimycin. These compounds are designed to inhibit glucosylceramidase and may be beneficial in treating diseases like Gaucher disease.
Career Highlights
He is affiliated with the Universiteit Van Amsterdam, where he conducts research and develops innovative solutions in his field. His work has garnered attention for its potential impact on therapeutic strategies for complex diseases.
Collaborations
Upendra Kumar Pandit has collaborated with esteemed colleagues, including Johannes Maria F G Aerts and Gerrit-Jan Koomen. These partnerships enhance the research and development of effective treatments in biochemistry.
Conclusion
Upendra Kumar Pandit is a prominent figure in the realm of biochemistry, with a focus on glucosylceramidase inhibitors. His innovative work and collaborations contribute significantly to the advancement of medical treatments for serious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile